glp-1 analogues market Size to Hit USD 1,062.90 Billion by 2035 Glucagon-like Peptide 1 (GLP-1) Analogues

Small but steady weight loss brought gains in confidence, energy, sleep, and quality of life

These drugs, like semaglutide, offer a comprehensive approach to managing diabetes and weight while influencing multiple bodily functions that ultimately improves fertility

Antioxidant and stress-response technologies complement structural, regenerative, and barrier-focused care because they address a different pathway involved in premature skin aging

The risk of muscle loss is particularly pronounced in certain populations: older adults (age 65+) who already face age-related sarcopenia, sedentary individuals without resistance training stimulus for muscle preservation, and patients losing weight very rapidly

In another study, participants were placed on a low-carbohydrate diet after stopping the medication, and the researchers reported that they maintained their weight loss